Sign In
Buy CSTL
$20.39
+0.680 (+3.45%)
At Close: Jun 03, 2026
Are You Looking for a Top Momentum Pick? Why Castle Biosciences, Inc. (CSTL) is a Great Choice
01:01pm, Friday, 23'rd Jan 2026
Does Castle Biosciences, Inc. (CSTL) have what it takes to be a top stock pick for momentum investors? Let's find out.
26,996 Shares in Castle Biosciences, Inc. $CSTL Acquired by Campbell & CO Investment Adviser LLC
03:51am, Thursday, 22'nd Jan 2026
Campbell and CO Investment Adviser LLC bought a new stake in shares of Castle Biosciences, Inc. (NASDAQ: CSTL) in the third quarter, according to its most recent filing with the Securities and Exchang
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
04:00pm, Sunday, 11'th Jan 2026
2025 total revenue expected to exceed $340 million, above the previously guided range of $327-335 million 2025 total test reports for our core revenue drivers (DecisionDx ® -Melanoma, TissueCypher ®
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of “Moderate Buy” by Analysts
01:30am, Wednesday, 07'th Jan 2026
Shares of Castle Biosciences, Inc. (NASDAQ: CSTL - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the firm, Market
Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus
11:21am, Monday, 29'th Dec 2025
Castle Biosciences surged 77.9% after a Zacks upgrade, highlighting how the firm's stock picks outpaced the broader market in recent months.
What Makes Castle Biosciences (CSTL) a Good Fit for 'Trend Investing'
09:56am, Wednesday, 24'th Dec 2025
Castle Biosciences (CSTL) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it t
Castle Biosciences (NASDAQ:CSTL) Hits New 12-Month High After Analyst Upgrade
01:16am, Tuesday, 23'rd Dec 2025
Castle Biosciences, Inc. (NASDAQ: CSTL - Get Free Report) shares hit a new 52-week high during trading on Monday after Canaccord Genuity Group raised their price target on the stock from $37.00 to $50
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells $20,380.36 in Stock
05:18am, Monday, 22'nd Dec 2025
Castle Biosciences, Inc. (NASDAQ: CSTL - Get Free Report) insider Derek Maetzold sold 509 shares of the business's stock in a transaction that occurred on Wednesday, December 17th. The stock was sold
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Friday, 19'th Dec 2025
FRIENDSWOOD, Texas, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on Dec.
FRIENDSWOOD, Texas, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data fro
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Average Rating of “Moderate Buy” from Analysts
01:16am, Saturday, 13'th Dec 2025
Castle Biosciences, Inc. (NASDAQ: CSTL - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the nine ratings firms that are covering the firm, MarketBeat Ratings repor
FRIENDSWOOD, Texas, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publicat
Are Medical Stocks Lagging Cronos Group (CRON) This Year?
10:40am, Thursday, 11'th Dec 2025
Here is how Cronos Group (CRON) and Castle Biosciences, Inc. (CSTL) have performed compared to their sector so far this year.
FRIENDSWOOD, Texas, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publicat
Here's Why 'Trend' Investors Would Love Betting on Castle Biosciences (CSTL)
09:56am, Monday, 08'th Dec 2025
Castle Biosciences (CSTL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed thr
